Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNYSE:ARDTNASDAQ:INNVNASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$112.31-0.7%$104.11$88.96▼$136.72$2.07B0.85168,621 shs238,885 shsARDTArdent Health Partners$14.48-1.5%$13.36$11.31▼$20.72$2.07BN/A390,149 shs205,309 shsINNVInnovAge$3.99-1.5%$3.26$2.60▼$6.69$538.70M0.452,477 shs43,709 shsWGSGeneDx$70.71+1.0%$82.39$19.54▼$117.75$2.02B1.96768,194 shs626,360 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-0.12%+1.43%+9.98%+18.13%+1.97%ARDTArdent Health Partners-0.94%-0.86%+16.52%+0.20%+1,468,999,900.00%INNVInnovAge0.00%+0.75%+32.79%+24.62%+0.25%WGSGeneDx-0.06%+3.94%-40.17%-31.96%+230.87%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.8505 of 5 stars3.63.00.05.03.42.52.5ARDTArdent Health Partners3.3307 of 5 stars3.50.00.00.02.90.03.1INNVInnovAge2.0405 of 5 stars2.83.00.00.02.91.70.6WGSGeneDx3.6224 of 5 stars2.43.00.00.04.25.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5726.94% UpsideARDTArdent Health Partners 3.00Buy$20.6742.73% UpsideINNVInnovAge 1.50Reduce$5.0025.31% UpsideWGSGeneDx 2.75Moderate Buy$86.7522.68% UpsideCurrent Analyst Ratings BreakdownLatest INNV, ARDT, ADUS, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2025ARDTArdent Health PartnersStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.005/15/2025ARDTArdent Health PartnersRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.005/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/9/2025ARDTArdent Health PartnersGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$16.00 ➝ $18.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.005/1/2025WGSGeneDxTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$135.00 ➝ $110.005/1/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/10/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/9/2025ARDTArdent Health PartnersGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$16.00(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.21B1.71$5.19 per share21.65$43.58 per share2.58ARDTArdent Health Partners$6.02B0.34N/AN/AN/A∞INNVInnovAge$831.68M0.65N/AN/A$1.90 per share2.10WGSGeneDx$330.14M6.11N/AN/A$8.78 per share8.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$62.52M$4.4325.7020.951.416.50%9.62%7.37%8/4/2025 (Estimated)ARDTArdent Health Partners$53.90M$1.638.887.39N/AN/AN/AN/A8/13/2025 (Estimated)INNVInnovAge-$21.34M-$0.23N/A66.50N/A-3.19%-9.45%-4.84%N/AWGSGeneDx-$175.77M-$1.41N/A33.83N/A-17.12%3.33%1.69%7/29/2025 (Estimated)Latest INNV, ARDT, ADUS, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025ARDTArdent Health Partners$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion5/6/2025Q3 2025INNVInnovAge-$0.02-$0.08-$0.06-$0.08$214.09 million$218.14 million5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 million4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AARDTArdent Health PartnersN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCareN/A2.112.11ARDTArdent Health Partners0.781.911.78INNVInnovAge0.271.161.16WGSGeneDx0.252.402.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%ARDTArdent Health PartnersN/AINNVInnovAge12.26%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%ARDTArdent Health Partners1.70%INNVInnovAge1.40%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare33,20018.40 million17.30 millionOptionableARDTArdent Health Partners24,200143.04 millionN/AOptionableINNVInnovAge2,000135.01 million133.35 millionOptionableWGSGeneDx1,20028.53 million19.97 millionOptionableINNV, ARDT, ADUS, and WGS HeadlinesRecent News About These CompaniesTidal Investments LLC Reduces Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)May 30 at 3:52 AM | marketbeat.comAmeriprise Financial Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 30 at 3:05 AM | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Given Average Rating of "Moderate Buy" by BrokeragesMay 30 at 2:45 AM | marketbeat.comWall Street Analysts Predict a 32.62% Upside in GENEDX HOLDINGS (WGS): Here's What You Should KnowMay 29 at 11:00 AM | zacks.comPolar Asset Management Partners Inc. Acquires Shares of 13,100 GeneDx Holdings Corp. (NASDAQ:WGS)May 29 at 5:14 AM | marketbeat.comDeutsche Bank AG Sells 113,731 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)May 29 at 3:29 AM | marketbeat.comTwo Sigma Advisers LP Invests $3.32 Million in GeneDx Holdings Corp. (NASDAQ:WGS)May 28 at 4:09 AM | marketbeat.comTwo Sigma Investments LP Acquires 111,657 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)May 26, 2025 | marketbeat.comJanus Henderson Group PLC Invests $430,000 in GeneDx Holdings Corp. (NASDAQ:WGS)May 26, 2025 | marketbeat.comPalisades Investment Partners LLC Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 24, 2025 | marketbeat.com61,710 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Purchased by Castleark Management LLCMay 24, 2025 | marketbeat.comPharVision Advisers LLC Buys Shares of 3,910 GeneDx Holdings Corp. (NASDAQ:WGS)May 24, 2025 | marketbeat.comGeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at ScaleMay 22, 2025 | finance.yahoo.comGeneDx to Participate in Upcoming Investor ConferencesMay 22, 2025 | businesswire.comPoint72 Asset Management L.P. Sells 230,583 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)May 22, 2025 | marketbeat.comSoleus Capital Management L.P. Invests $307,000 in GeneDx Holdings Corp. (NASDAQ:WGS)May 21, 2025 | marketbeat.comSilvercrest Asset Management Group LLC Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 21, 2025 | marketbeat.comGeneDx: Strong Fundamentals Intact As Market Misreads Test Volume DipMay 20, 2025 | seekingalpha.com13,100 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Polar Asset Management Partners Inc.May 20, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Summit Partners Public Asset Management LLCMay 19, 2025 | marketbeat.comRedwood Investment Management LLC Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS)May 19, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINNV, ARDT, ADUS, and WGS Company DescriptionsAddus HomeCare NASDAQ:ADUS$112.31 -0.82 (-0.72%) Closing price 04:00 PM EasternExtended Trading$110.94 -1.37 (-1.22%) As of 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Ardent Health Partners NYSE:ARDT$14.48 -0.22 (-1.50%) Closing price 03:59 PM EasternExtended Trading$14.48 -0.01 (-0.03%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.InnovAge NASDAQ:INNV$3.99 -0.06 (-1.48%) Closing price 04:00 PM EasternExtended Trading$4.17 +0.18 (+4.49%) As of 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.GeneDx NASDAQ:WGS$70.71 +0.73 (+1.04%) Closing price 04:00 PM EasternExtended Trading$71.55 +0.84 (+1.19%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Archer Aviation Stock Steadies After Short-Seller Report e.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
